Mechanisms and consequences of CD19 loss in B-acute lymphoblastic leukaemia patients relapsing after CD19-CAR-T cell therapy: identification of novel therapeutic vulnerabilities

2021/43/O/NZ5/02693

Keywords

Descriptors

  • NZ5_007: Leczenie chorób człowieka
  • NZ2_002: Genomika, transkryptomika i epigenomika
  • NZ2_007: Bioinformatyka

Panel

NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution

Instytut Hematologii i Transfuzjologii

Voivodeship: mazowieckie

Other projects carried out by the institution »

Principal investigator (from the host institution)

prof. Przemysław Juszczyński

Number of co-investigators in the project: 2

Call

PRELUDIUM BIS 3 – announced on 2021-09-15

Amount awarded
686 800 PLN
Project start date
2022-10-01
Project end date
2026-09-30
Project duration
48 months (the same as in the proposal)
Project status
Pending project

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

« New search

Graphic design and implementation: Jakub Piotrowski